VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ESH AL 2020 | Impact of increased drug availability on acute leukemia

A higher number of drugs available as potential treatment options for leukemia means that there has to be increased opportunity for testing, trials and higher patient numbers. Oliver Ottmann, MD, FRCPath, University of Cardiff, Cardiff, UK, talks about the importance of trials and combination drug therapy when treating acute leukemia. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter